Related Experiment Video
Updated: Jan 27, 2026

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement
Published on: January 20, 2022
Impact of Chronic Kidney Disease on Decision Making and Management in Transcatheter Aortic Valve Interventions
Mark Hensey1, Dale J Murdoch1, Janarthanan Sathananthan1
1Centre for Heart Valve Innovation, St Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
Insights
Chronic kidney disease (CKD) and severe aortic stenosis (AS) often coexist, impacting treatment decisions for transcatheter aortic valve implantation (TAVI). This review addresses TAVI challenges and management strategies in patients with both conditions.
Area of Science:
- Cardiology
- Nephrology
- Interventional Cardiology
Background:
- The prevalence of chronic kidney disease (CKD) and severe aortic stenosis (AS) is increasing.
- CKD and AS have a bidirectional relationship, with each condition potentially worsening the other.
- Transcatheter aortic valve implantation (TAVI) is increasingly used for severe AS, presenting unique challenges in patients with CKD.
Purpose of the Study:
- To review the current literature on TAVI in patients with concomitant severe AS and CKD.
- To focus on the decision-making process and specific risks associated with TAVI in this patient cohort.
- To provide practical strategies for managing patients with both severe AS and CKD undergoing TAVI.
Main Methods:
- Literature review of studies concerning TAVI in patients with CKD.
- Analysis of diagnostic, therapeutic, and interventional considerations.
- Synthesis of current evidence and clinical recommendations.
Main Results:
- CKD significantly impacts diagnostic investigations and treatment decisions for TAVI.
- Specific risks related to TAVI procedures in CKD patients require careful consideration.
- Management strategies need to be tailored to the individual patient's renal function and cardiovascular status.
Conclusions:
- Optimal management of severe AS with TAVI in CKD patients requires a multidisciplinary approach.
- Careful pre-procedural assessment and risk stratification are crucial.
- Further research is needed to refine TAVI techniques and post-procedural care in this complex population.
Abstract:
The coexistence of chronic kidney disease (CKD) and severe aortic stenosis (AS) is common, and the prevalence of both is rising. The 2 conditions are inherently linked in that significant CKD may accelerate the development of AS and severe AS may result in deteriorating kidney function. The volume of and indications for transcatheter aortic valve implantation (TAVI) procedures are ever-increasing, and there are many challenges that need to be considered in patients with concomitant severe AS and CKD being assessed for TAVI. Throughout the process of working these patients up for definitive management of their valvular heart disease, the presence of CKD impacts on diagnostic investigations, treatment decisions, and therapeutic interventions. Herein we review the current literature regarding TAVI in patients with CKD focusing on the decision-making process and specific risks involved in TAVI and CKD. We also provide specific practical strategies to best manage this challenging patient cohort.
Related Concept Videos
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Kidney Disease III: Interprofessional Care
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment

